Merck

Merck cuts ties to Moderna's early-phase KRAS vaccine, leaving mRNA specialist to mull next steps
Fierce Biotech
Thu, 02/24/22 - 09:58 am
Merck
Moderna Therapeutics
KRAS
vaccines
mRNA-5671
Merck’s Anti-Covid Pill Shows Better Effectiveness In Indian Study
Forbes
Sun, 02/20/22 - 11:56 am
Merck
Ridgeback Biotherapeutics
molnupiravir
antivirals
COVID-19
ASCO-GU – prostate cancer PARPS move to the front line
EP Vantage
Sun, 02/20/22 - 11:44 am
prostate cancer
ASCO-GU
PARP inhibitors
Lynparza
Zejula
Rubraca
Talzenna
biomarkers
AstraZeneca
Merck
GSK
JNJ
Clovis Oncology
FDA updates Merck's Covid-19 pill EUA and reaffirms it should only be used as a last resort
Endpoints
Fri, 02/18/22 - 10:25 am
Merck
molnupiravir
FDA
Pfizer
COVID-19
antivirals
Paxlovid
Merck promotes 3 executives to lead human health business
BioPharma Dive
Wed, 02/16/22 - 11:09 pm
Merck
human health
Merck gets ahead of the Curve, inking oncology and neurology drug discovery deal with emerging British biotech
Fierce Biotech
Wed, 02/16/22 - 10:29 am
Merck
Curve Therapeutics
small molecule drugs
oncology
UK
drug discovery
AstraZeneca/Merck come out of ASCO GU with a big win over J&J in battle over prostate cancer franchises
Endpoints
Tue, 02/15/22 - 11:31 pm
AstraZeneca
Merck
JNJ
ASCO
prostate cancer
Lynparza
COVID-19 treatments earned 4 drugmakers $14B in 2021
Beckers Hospital Review
Tue, 02/8/22 - 11:50 pm
Eli Lilly
Gilead Sciences
Merck
Regeneron
COVID-19
earnings
Pharma's cyber vulnerabilities run deeper than Merck's 'NotPetya' attack: report
Fierce Pharma
Mon, 02/7/22 - 11:26 am
Merck
cybersecurity
cyberattacks
Takeda joins Novartis and Merck in $45M funding for Koneksa Health
Fierce Biotech
Mon, 02/7/22 - 10:10 am
Takeda Ventures
Novartis
Merck
Koneska Health
biomarkers
digital biomarkers
funding
Will a New FDA-Approved COVID Pill Propel This Healthcare Company's Stock?
Motley Fool
Sat, 02/5/22 - 12:04 pm
FDA
Merck
COVID-19
molnupiravir
'We need to do more': Merck CEO Rob Davis highlights M&A, deals strategy ahead of '28 Keytruda patent cliff
Endpoints
Fri, 02/4/22 - 11:13 am
Merck
Pharma CEOs
Rob Davis
M&A
Keytruda
patent cliff
Organon gives staff the day off for International Women's Day to focus on their health
Fierce Pharma
Wed, 02/2/22 - 11:07 am
Organon
Merck
Women's Health
employee satisfaction
employees
Can A New Cholesterol Drug Restore Merck’s Prominence In Heart Drugs?
Forbes
Tue, 02/1/22 - 10:48 am
Merck
cholesterol
PCSK9 inhibitors
MK-0616
Zocor
Digital collaboration here to stay beyond pandemic for Merck, Pfizer, others
MedCity News
Tue, 02/1/22 - 10:29 am
digital pharma
pandemic
COVID-19
Merck
Pfizer
virtual meetings
Blockbuster cancer med Keytruda may help flush out dormant HIV, suggesting a new way to treat long-running epidemic
Fierce Biotech
Thu, 01/27/22 - 11:38 pm
HIV
Merck
Keytruda
Merck: FDA Rejects Gefapixant Application, Requests More Data
Marketwatch
Mon, 01/24/22 - 10:22 am
Merck
chronic cough
FDA
gefapixant
27 drugmakers to provide generic COVID drug to low-income countries
Pharmaforum
Thu, 01/20/22 - 11:29 pm
generics
Merck
molnupiravir
COVID-19
antivirals
Top Merck executive to depart company for CEO role at ingredients maker
BioPharma Dive
Thu, 01/20/22 - 11:26 pm
Merck
Frank Clyburn
IFF
Merck scores a win in $1.4B insurance fight over devastating cyberattack
Fierce Pharma
Thu, 01/20/22 - 10:50 am
Merck
cybersecurity
cyberattack
insurance

Pages